Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina
Background A first-dose of various vaccines provides acceptable protection against infections by SARS-CoV-2 and evolution to the most severe forms of COVID-19. The recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), was proven efficacious but information about effectiveness in the...
Guardado en:
| Autores principales: | González, Soledad E., Olszevicki, Santiago, Salazar, Martín R., Calabria, Ana, Regairaz, Lorena, Marín, Lupe, Campos, Patricia, Varela, Teresa, González Martínez, Veronica V., Ceriani, Leticia, Garcia, Enio, Kreplak, Nicolás, Pifano, Marina, Estenssoro, Elisa, Marsico, Franco |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/142736 |
| Aporte de: |
Ejemplares similares
-
Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity to SARS CoV-2 after a Single Dose
por: Rossi, Andrés Hugo, et al.
Publicado: (2021) -
Prevalencia de anticuerpos anti SARS-CoV-2 en personal de salud vacunado con Sputnik V en Villa Ángela, Chaco
por: Zago, Milena Carolina
Publicado: (2025) -
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort
por: Blanco, Sebastián, et al.
Publicado: (2023) -
SARS-CoV-2 : abordaje multidisciplinario /
Publicado: (2021) -
Sputniks and after
por: Gilzin, Karl Alexandrovich
Publicado: (1959)